Expanding Virtual Care to Uro-Oncology.
Kranus Health is providing a full range of therapies from Andrology to Uro-Oncology, actively broadening its array of virtual care journeys backed by clinical evidence.
Treatment landscape for Prostate Cancer has dramatically expanded.
Patients need better support during their oncology treatment with:
• Psychological distress
• Physical impairment
• Cognitive impairment
• Disease symptoms
• Tracking and treatment of side-effects
• Patient education
Our Approach: Evidence-Based Science developed with a diverse Medical Advisory Board.
Prof. Laura Maria Krabbe
Medical Advisor
Chief Physician of Urology at Vivantes Humboldt Hospital since 2023
Prof. Dr. Oliver Grimm
Medical Advisor
Director of the Clinic for Urology, University Hospital Jena, Chairman of the Steering Committee for the S3 Guideline on Prostate Cancer
Prof. Dr. Mehnert-Theuerkauf
Medical Advisor
Chair in Medical Psychology and Medical Sociology, University Medical Center Leipzig
Prof. Dr. Maria De Santis
Medical Advisor
Head of the Department of Interdisciplinary Urological Oncology at Charité
Prof. Dr. Freerk Baumann
Medical Advisor
Leader Studygroup Oncological Exercise University of Cologne (UOC)
Dr. Laura Wiemer
Chief Scientific Officer
Practicing urologist with additional qualifications in medical tumor therapy and former Charite doctor in urology and andrology
Prof. Dr. Kurt Miller
Chief Medical Officer
Former Medical Director of the Department of Urology at the Charité in Berlin
Prof. Dr. Ehsan Khaljani
Senior Advisor
Urologist and Head of the Digital Health Management program at Medical School Berlin
Dr. Eva Hellmis
Medical Advisor
Specialist in urology with additional qualifications in medical tumor therapy, andrology, and palliative medicine
Transforming Prostate Cancer Care.
The multimodal therapy for self-treatment includes:
• Symptom and Side-effect Management
• Psycho-oncology Intervention
• Cardiovascular & Resistance Training
• Meditation & Cognitive Exercises
• Knowledge Section including nutrition tips
Creating a Holistic Therapy View.
Symptom and side-effect tracking combined with wearable data, PROMs, PSA Tracking and adherence to medications will provide a holostic therapy view.
• Symptom tracking
• PROMs
• PSA
• Medication adherence
• Wearable data
Empowering Doctors: Streamlined Care, Enhanced Monitoring.
• Reduced patient education time
• Enhanced therapy monitoring capabilities
• Practical information for patients to reference after the initial shock
• Improved side effect management
• Patients seek medical assistance only when necessary
Development is fully under way, the product will be completed this year.
Next step: Start of clinical trial A prospective randomized study on multimodal self-treatment of men with prostate cancer under drug therapy.
Diagnoses: Men with prostate cancer undergoing drug therapy (ADT and combination therapies)
ICD-10 code: C61